| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/22/2011 | US20110230393 Antibacterial Phage Peptides and Methods of Use thereof |
| 09/22/2011 | US20110230392 Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses therefor |
| 09/22/2011 | US20110230365 Mutations Associated With Cystic Fibrosis |
| 09/22/2011 | US20110229980 Oligonucleotide probe and use thereof |
| 09/22/2011 | US20110229964 Fusion Protein Delivery System and Uses Thereof |
| 09/22/2011 | US20110229958 Host Cells for Production of Isoprenoid Compounds |
| 09/22/2011 | US20110229957 Polymer-mediated electromagnetic field-based particle concentrator |
| 09/22/2011 | US20110229956 Novel Variant Hyprocrea Jecorina CBH1 Cellulases |
| 09/22/2011 | US20110229955 Luciferases and methods for making and using the same |
| 09/22/2011 | US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof |
| 09/22/2011 | US20110229941 Novel Gene Cluster |
| 09/22/2011 | US20110229936 Polypeptides Having Beta-Glucosidase Activity And Polynucleotides Encoding Same |
| 09/22/2011 | US20110229920 Screening methods for identifying specific staphylococcus aureus inhibitors |
| 09/22/2011 | US20110229903 Determination of immunoglobulin encoding nucleic acid |
| 09/22/2011 | US20110229902 Method for determining the resistance status of fungi and yeasts, in particular of aspergillus fumigatus |
| 09/22/2011 | US20110229901 Methods for identifying the habitats of insects |
| 09/22/2011 | US20110229899 DETECTION OF MUTATIONS IN A GENE ENCODING IkB KINASE-COMPLEX-ASSOCIATED PROTEIN TO DIAGNOSE FAMILIAL DYSAUTONOMIA |
| 09/22/2011 | US20110229894 Methods for detecting an increased susceptibility to cancer |
| 09/22/2011 | US20110229893 METHOD OF MEASURING CYTOKERATIN 19 mRNA |
| 09/22/2011 | US20110229892 Method for predicting a patient's responsiveness to anti-folate therapy |
| 09/22/2011 | US20110229891 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
| 09/22/2011 | US20110229889 DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Msx1/2 |
| 09/22/2011 | US20110229888 Compositions and Methods for the Detection of Genomic Features |
| 09/22/2011 | US20110229884 Method of genome-wide nucleic acid fingerprinting of functional regions |
| 09/22/2011 | US20110229881 Dna-containing ink composition |
| 09/22/2011 | US20110229878 Human consensus sodium-iodide symporter repressor (nis-repressor) binding site |
| 09/22/2011 | US20110229877 Enzyme-pore constructs |
| 09/22/2011 | US20110229706 Aligned nanostructured polymers |
| 09/22/2011 | US20110229558 Agent for treating myelofibrosis |
| 09/22/2011 | US20110229557 Methods for treating eye disorders |
| 09/22/2011 | US20110229552 NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN |
| 09/22/2011 | US20110229531 Anti-protozoa compounds |
| 09/22/2011 | US20110229525 Modulation of cytokine signaling |
| 09/22/2011 | US20110229518 Optimized influenza vaccines |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229509 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229508 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229504 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 09/22/2011 | US20110229498 Compositions and methods for modulating an immune response |
| 09/22/2011 | US20110229489 Antibodies with pH Dependent Antigen Binding |
| 09/22/2011 | US20110229485 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 09/22/2011 | US20110229481 Cancer-associated antigen analogue peptides and uses thereof |
| 09/22/2011 | US20110229480 Pta072 protein |
| 09/22/2011 | US20110229479 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| 09/22/2011 | US20110229478 Erbb3 based methods and compositions for treating neoplasms |
| 09/22/2011 | US20110229472 Peptides and Related Compounds Having Thrombopoietic Activity |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229458 Methods for selecting protease resistant polypeptides |
| 09/22/2011 | US20110229456 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 09/22/2011 | US20110229451 Temperature sensitive mutants of matrix metalloproteases and uses thereof |
| 09/22/2011 | US20110229450 Enzymes and methods for degrading s-triazines and diazines |
| 09/22/2011 | US20110229449 Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein |
| 09/22/2011 | US20110229423 Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereof |
| 09/22/2011 | US20110229408 Sodium-iodide symporter gene repressor binding site |
| 09/22/2011 | CA2793660A1 Methods, kits and compositions for detection of mrsa |
| 09/22/2011 | CA2793373A1 Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery |
| 09/22/2011 | CA2793309A1 Method of producing transcripts using cryptic splice sites |
| 09/22/2011 | CA2791094A1 Light-sensitive ion-passing molecules |
| 09/21/2011 | EP2366803A2 Compositions and methods for detecting west nile virus |
| 09/21/2011 | EP2366797A1 Compositions and processes for analyte detection; quantification and amplification |
| 09/21/2011 | EP2366785A1 Oligonucleotide derivative, labeling agent, and use of the labeling agent |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366706A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 09/21/2011 | EP2366705A1 Methods for synthesis of encoded libraries |
| 09/21/2011 | EP1751280B1 Tobacco nicotine demethylase genomic clone and uses thereof |
| 09/21/2011 | EP1573009B1 Detection of small nucleic acids |
| 09/21/2011 | EP1296998B1 Hcv variants |
| 09/21/2011 | EP1073905B1 Methods of selecting internalizing antibodies |
| 09/21/2011 | EP1068357B1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 09/21/2011 | CN1902310B Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 09/21/2011 | CN102197145A Gene expression profiles associated with lean phenotype and uses thereof |
| 09/21/2011 | CN102197047A Mutant delta5 desaturases and their use in making polyunsaturated fatty acids |
| 09/21/2011 | CN102197043A Hydrolases, nucleic acids encoding them and methods for making and using them |
| 09/21/2011 | CN102191238A Method for extracting small molecular RNA |
| 09/20/2011 | US8022275 Maize promoter active in silk and pericarp tissues |
| 09/20/2011 | US8022272 Expression cassettes for transgenic expression of nucleic acids |
| 09/20/2011 | US8022271 Polyubiquitin Rubi3 promoter and 5' regulatory sequences |
| 09/20/2011 | US8022199 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 09/20/2011 | US8022198 siRNA targeting histamine receptor H1 |
| 09/20/2011 | US8022197 Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene |
| 09/20/2011 | US8022196 Polynucleotides and polypeptides involved in post-transcriptional gene silencing |
| 09/20/2011 | US8022195 Expression vector comprising nucleotide sequences coding UP50 protein and endothelial growth factor for use in treatment of vascular disorders; regenerative medicine; tissue engineering and repair |
| 09/20/2011 | US8022194 2′-nitrobenzyl-modified ribonucleotides |
| 09/20/2011 | US8022193 6-modified bicyclic nucleic acid analogs |
| 09/20/2011 | US8022188 Immunosuppressant binding antibodies and methods of obtaining and using same |
| 09/20/2011 | US8022177 Peptides and calcium regulation in mammalian cells |
| 09/20/2011 | US8022046 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 09/20/2011 | US8022045 Inhibitors of TGF-R-signaling for treatment of CNS disorders |
| 09/20/2011 | US8021888 Rapid comparative genomic hybridization using acoustic surface waves |
| 09/20/2011 | US8021879 Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 09/20/2011 | US8021878 Regulatory switches for controlling insect development; biological pest control |
| 09/20/2011 | US8021866 Therapeutic use of ADPase enhanced apyrases |
| 09/20/2011 | US8021860 Method for producing human antibodies to a self physiological receptor by site-directed in vitro immunization of human lymphocytes |
| 09/20/2011 | US8021857 Glyphosate-N-acetyltransferase (GAT) genes |
| 09/20/2011 | US8021856 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells |
| 09/20/2011 | US8021853 Inhibition of the β3 subunit of L-type Ca2+ channels |